Repositorio Institucional
Repositorio Institucional
CONICET Digital
  • Inicio
  • EXPLORAR
    • AUTORES
    • DISCIPLINAS
    • COMUNIDADES
  • Estadísticas
  • Novedades
    • Noticias
    • Boletines
  • Ayuda
    • General
    • Datos de investigación
  • Acerca de
    • CONICET Digital
    • Equipo
    • Red Federal
  • Contacto
JavaScript is disabled for your browser. Some features of this site may not work without it.
  • INFORMACIÓN GENERAL
  • RESUMEN
  • ESTADISTICAS
 
Artículo

Suppression of cancer growth by non-viral gene therapy based on a novel reactive oxygen species-responsive promoter

Policastro, Lucia LauraIcon ; Ibañez, Irene LauraIcon ; Duran, Hebe AliciaIcon ; Soria, Ramiro GastonIcon ; Gottifredi, VanesaIcon ; Podhajcer, Osvaldo LuisIcon
Fecha de publicación: 08/2009
Editorial: Cell Press
Revista: Molecular Therapy (print)
ISSN: 1525-0016
Idioma: Inglés
Tipo de recurso: Artículo publicado
Clasificación temática:
Bioquímica y Biología Molecular

Resumen

Increased reactive oxygen species (ROS) production has been reported as a distinctive feature of different pathologies including cancer. Therefore, we assessed whether increased ROS production in the cancer microenvironment could be selectively exploited to develop a selective anti-cancer therapy. For this purpose we constructed a novel chimeric promoter, based on a ROS-response motif located in the VEGF gene promoter placed, in turn, downstream of a second ROS-response motif obtained from the early growth response 1 (Egr-1) gene promoter. The activity of the chimeric promoter was largely dependent on variations in intracellular ROS levels and showed a high inducible response to exogenous H2O2. Transient expression of the thymidine kinase gene (TK) driven by the chimeric promoter, followed by gancyclovir administration, inhibited human colorectal cancer and melanoma cell growth in vitro and in vivo. Moreover, electrotransfer of the TK gene followed by gancyclovir (GCV) administration exerted a potent therapeutic effect on established tumors. This response was improved when combined with chemotherapeutic drugs. Thus, we show for the first time that a distinctive pro-oxidant state can be used to develop new selective gene therapeutics for cancer.
Palabras clave: Reactive Oxygen Species , Cancer , Gene Therapy , Chimeric Promoter
Ver el registro completo
 
Archivos asociados
Thumbnail
 
Tamaño: 417.9Kb
Formato: PDF
.
Descargar
Licencia
info:eu-repo/semantics/openAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Atribución-NoComercial-SinDerivadas 2.5 Argentina (CC BY-NC-ND 2.5 AR)
Identificadores
URI: http://hdl.handle.net/11336/25652
URL: http://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-00
DOI: http://dx.doi.org/10.1038/mt.2009.103
Colecciones
Articulos(OCA CIUDAD UNIVERSITARIA)
Articulos de OFICINA DE COORDINACION ADMINISTRATIVA CIUDAD UNIVERSITARIA
Articulos(SEDE CENTRAL)
Articulos de SEDE CENTRAL
Citación
Policastro, Lucia Laura; Ibañez, Irene Laura; Duran, Hebe Alicia; Soria, Ramiro Gaston; Gottifredi, Vanesa; et al.; Suppression of cancer growth by non-viral gene therapy based on a novel reactive oxygen species-responsive promoter; Cell Press; Molecular Therapy (print); 17; 8; 8-2009; 1355-1364
Compartir
Altmétricas
 

Enviar por e-mail
Separar cada destinatario (hasta 5) con punto y coma.
  • Facebook
  • X Conicet Digital
  • Instagram
  • YouTube
  • Sound Cloud
  • LinkedIn

Los contenidos del CONICET están licenciados bajo Creative Commons Reconocimiento 2.5 Argentina License

https://www.conicet.gov.ar/ - CONICET

Inicio

Explorar

  • Autores
  • Disciplinas
  • Comunidades

Estadísticas

Novedades

  • Noticias
  • Boletines

Ayuda

Acerca de

  • CONICET Digital
  • Equipo
  • Red Federal

Contacto

Godoy Cruz 2290 (C1425FQB) CABA – República Argentina – Tel: +5411 4899-5400 repositorio@conicet.gov.ar
TÉRMINOS Y CONDICIONES